ArticleCell reports. Medicine2024

Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors.

Dennis S Metselaar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.